Safety and Hemodynamic Effects of Intravenous Triiodothyronine in Advanced Congestive Heart Failure
- 1 February 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 81 (4) , 443-447
- https://doi.org/10.1016/s0002-9149(97)00950-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Acute Effects of Thyroid Hormone on Vascular Smooth MuscleThyroid®, 1996
- Nongenomic Actions of Thyroid HormoneThyroid®, 1996
- Cardiovascular Effects of Intravenous Triiodothyronine in Patients Undergoing Coronary Artery Bypass Graft SurgeryJAMA, 1996
- Thyroid Hormone Treatment after Coronary-Artery Bypass SurgeryNew England Journal of Medicine, 1995
- The direct effects of 3,5,3′-triiodo-L-thyronine (T3) on myocyte contractile processes: Insights into mechanisms of actionThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemiaThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failureThe Annals of Thoracic Surgery, 1993
- Altered thyroid hormone metabolism in advanced heart failureJournal of the American College of Cardiology, 1990
- Treatment of dopamine-dependent shock with triiodothyronineEndocrine Research Communications, 1981
- The Pathogenesis of Cardiac CachexiaNew England Journal of Medicine, 1964